{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002466","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001305081","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["20 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K27ac"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20  ul"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0  ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33  ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["184"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"768K","NAME":"S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151026.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151026.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"597f1acd0c6216383b156047ee2e75e0"},{"FORMAT":"BED","SIZE":"631K","NAME":"S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151026.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151026.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"ded56add82af91fd25aaa08d59ef8fc1"},{"FORMAT":"Text","SIZE":"746K","NAME":"S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151026.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151026.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"1a54ff2f64855268abe8a60497d5cf2e"},{"FORMAT":"bigWig","SIZE":"1.2G","NAME":"S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151029.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1007481.H3K27ac.bwa.GRCh38.20151029.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"8747d1870094be6a6e107065f4cd9feb"}],"dataset_id":"EGAD00001002466","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"B15_50","sample_barcode":"S0159LH1","attributes":{"DISEASE":["None"],"TREATMENT":["NA"],"CELL_TYPE":["naive B cell"],"DISEASE_ONTOLOGY_URI":["NA"],"SAMPLE_ONTOLOGY_URI":[{"url":"8","label":"CL_0000788"}],"GENDER":["female"],"DONOR_ID":["B15_50"],"PASSAGE_IF_EXPANDED":["NA"],"MARKERS":["CD19+,CD27-,IgD+"],"DONOR_HEALTH_STATUS":["Healthy"],"MOLECULE":["genomic DNA"],"DONOR_AGE":["55 - 60"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"TISSUE_TYPE":["venous blood"],"BIOMATERIAL_TYPE":["Primary Cell"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001277492","SAMPLE_DESCRIPTION":"naive B cell"}}